Questions for the Harvard case “Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug” For March 20‚ write responses to the following questions for the Metabical case. 1) How is Metabical different from the existing weight-loss options? How is it better or worse than the other options? Metabical is the first prescription drug approved specifically for overweight individuals (BMI between 25 and 30)‚ those individuals who have weight-loss goals of approximately
Premium Obesity Weight loss Nutrition
1. How does Metabical compare to current weight-loss options? * It was the only prescription drug to achieve the FDA * No side effects * Moderate weight loss for overweight people not the obese like other weightloss drugs * Dual layer controlled realise formulation. First layer appetite suppressant‚ 2nd layer is the fat blocker. Low dose levels of chemicals‚ so doesn’t cause heart or liver diseases. 2. What are the pros and cons of the forecasting methods presented by Printup
Premium Obesity Weight loss
Metabical: Positioning and Communications Strategy for a new Weight-Loss Drug Q & A 1. Who is involved in the decision making process? What is the decision making process for Metabical? Since Metabical is a prescription drug for weight loss which can only be bought via a prescription‚ the overweight patients are not the only decision makers involved. The health care providers are also decision makers in this process for they are the ones who prescribe the drug. The consumer decision
Premium Marketing Obesity Medicine
Metabical: Positioning and Communications Strategy for a New Weight-Loss Drug Case Study Case Article:Click Here Questions for Analysis 1. Metabical is faced with the task of positioning their product in the marketplace. Using the information from the case and your assigned readings‚ who are the key target segments for Metabical and what points of difference should be directed to each segment? Key Segments for Metabical are 1. End consumer(the patient) - Over weight adults
Premium Health care Medicine Marketing
HBS Case: Metabical: Positioning and Communications Strategy for a New Weight Loss Drug 1. What is the decision-making process for Metabical? Who is involved? Metabical needs to decide whom to sell and what means to use in order to reach this group successfully. This decision has to be taken by Printup and her marketing team. The target market should be identified; first of all‚ the segmentation of the market needs to be done in order to analyze which segment of the market would be more attracted
Premium Obesity Weight loss Medicine
Nguyen New Product Planning Professor Patton 3/5/14 Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug Case 1. How does Metabical compare to current weight-loss options? There are only several other weight-loss options in the market competing with Metabical. The first is prescription drugs. These are prescribed for use only by obese and severely obese individuals. This meant that only individuals with BMI of over 30 who were prescribed weight-loss drugs were
Premium Obesity Medical prescription Drugs
Hello Metabical Positioning And Communications Strategy For a New Weight Loss Drug Harvard Business Essays and Term Papers Search Results for ’metabical positioning and communications strategy for a new weight loss drug harvard business ’ Displaying 1 - 30 of 1‚500 * Metabical: Positioning And Communications Strategy For a New Weight-Loss Drug Metabical: Positioning and Communications Strategy for a new Weight-Loss Drug Q & A 1. Who is involved in the decision making process? What
Premium Marketing Weight loss
Metabical (Case study) Case Facts • Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss. • It was the first and only prescription drug to obtain FDA approval for weight loss (overweight category) drug. • The company had conducted an elaborate market research program for identifying the target segment and positioning the product. • Competitors: FDA approved OTC drug Alli. • Marketing strategy: – DTC advertising- celebrity endorser‚ TV‚ radio‚
Premium Obesity Food and Drug Administration Marketing
How does Metabical compare to current weight-loss options? Answer: Metabical is revolutionary product and forecasted to be the first FDA approved prescriptive drug for overweight individuals with weight-loss goals. The previous prescriptive drugs have a negative side effects that out weighed its positives. Metabical‚ on the other hand‚ did not display as many negative effects in its trail runs and thus was being strongly endorsed by the medical community. The current weight-loss drugs can be classified
Premium Obesity Weight loss Cancer
Schedule for Key Marketing Communication Activities 4.4 Promotional Strategies 4.4.1 Advertising Strategies 4.4.2 Promotion and Public Relations 4.4.3 Sales Force 4.4.4 Comprehensive Support Program 4.5 Product Strategies 4.6 Distribution Strategies 4.7 Pricing Strategies 4.7.1 Potential Customer 4.7.2 Sales Forecast 4.7.3 Return on Investment (ROI) Conclusion 4.0 5.0 1 1.0 INTRODUCTION Cambridge Science Pharmaceuticals (CSP) was an International health care company with a focus on developing
Premium Marketing Obesity Weight loss